Volunteering for a Clinical Trial
Overview - What Veterans Should Know
The Department of Veterans Affairs (VA) Cooperative Studies Program (CSP) is a research
organization in the Veterans Health Administration's Office of Research and Development.
The CSP works with VA doctors to conduct clinical trials. The CSP also collaborates with others,
such as the National Institutes of Health, universities and the pharmaceutical industry on these
trials. The goal of clinical trials is try to compare and/or find treatments for diseases that
affect our nation's veterans. Since many other people in the country also have these diseases,
the results of CSP trials often improve and benefit the health of the United States population.
In fact, CSP research has found better ways of treating diabetes, tuberculosis, high blood pressure,
prostate cancer and many other illnesses.
The following information describes what clinical trials are and gives additional information to help
you decide if participating in a clinical trial is right for you.
What Is a Clinical Trial?
A clinical trial is an organized way of studying medical treatments for diseases.
Medical treatments are medicines, devices or procedures.
Clinical trials are research studies that help prove that medical treatments are safe and effective to use.
They also can show whether one medical treatment is better than another.
At first, studies of new medicines are done in laboratories. If the medicine looks promising, it is then tested in
animals. Usually, clinical trials are only started after the treatment is found to be safe in animals. Most clinical
trials involve many people. This way, if the medical treatment is shown to be safe and effective, doctors will know
what to expect in their patients.
What Types of Clinical Trials Are There?
Generally, there are two types of clinical trials, uncontrolled and controlled. In an
uncontrolled clinical trial, all participants
simply receive the same treatment. However, these types of trials do not provide as much
information as a controlled clinical trial.
In a controlled clinical trial, participants are
divided into two groups. The first group, called the treatment group
(or experimental group) may receive one or more kinds of treatment.
The other type of group, called the control group, receives the standard
treatment. Sometimes in medical trials, there is no standard treatment so a
placebo or "sugar" pill is used. By dividing participants into groups, doctors
can compare how well different treatments work.
An important part of a controlled clinical trial is that participants are randomly assigned to one of the two
groups (see Figure). A participant who is randomly assigned means he or she is assigned to a group by chance
(like a flip of a coin). A randomized clinical trial is the best way to study
Often controlled clinical trials are also masked. There are two types of masked clinical trial designs,
single masked and double masked. In a
single masked clinical trial, participants do not know whether they received the new treatment or a standard
treatment (or placebo) until the end of the study. In this type of clinical trial, the doctor and nurse know
which treatment the participant received. In a double masked trial, neither the participant nor the doctor/nurse
know whether the participant received the new treatment or a standard treatment (or placebo) until the end of the
study. These clinical trial methods are important because they prevent people's behaviors or opinions from
influencing the results of the clinical trial.
What Are Clinical Trial Phases?
Clinical trials of medications involve four phases. Phase I clinical trials
usually include between 20 to 80 healthy people. These clinical trials make sure a medication is safe.
Phase II clinical trials are done only after a medication is shown to be safe.
Phase II clinical trials involve no more than a few hundred participants who have the disease that the
medication is intended to treat. These clinical trials are used to learn if the medication works and
determines what dose should be used for the disease.
Phase III clinical trials can include up to several thousand participants.
These clinical trials try to further confirm that the medication works for a specific disease. Phase III
clinical trials also study the side effects of the medication. Both Phase II and Phase III clinical trials
may compare the effectiveness of a new medication to a control group, who gets the standard treatment (or placebo).
After a Phase III clinical trial is completed, data from some of the clinical trials can be sent to the
Food and Drug Administration (FDA). If the FDA decides that the medication is safe
and effective to use, it can then be marketed and prescribed by your doctor.
Once a medication is marketed, Phase IV clinical trials may be done. Phase IV
clinical trials often include several thousand participants. These clinical trials provide additional information
about the medication's effectiveness and safety. Specifically, these trials continue to collect information on the
long-term side effects of a marketed medication. This information is later sent to the FDA.
Medical and surgical procedures, herbal remedies and dietary supplements are less regulated and do not go through
Why Are Clinical Trials Important?
Many important medical questions have been answered with clinical trials. These answers have helped improve
medical care. Clinical trials usually lead to safer and more effective treatments for many diseases. They also
show new directions for medical research that may lead to new therapies in the future.
VA clinical trials have found new therapies for heart failure, high blood pressure, coronary artery disease,
stroke, tuberculosis, epilepsy, diabetes, kidney disease and gastrointestinal diseases.
Why Would a Person Be Interested in a Clinical Trial?
There are many good reasons to take part in a clinical trial. In clinical trials, doctors discover
new ways of curing or relieving symptoms of diseases. Many people choose to take part in a trial because
the new treatment may help themselves or others.
In some clinical trials, a new treatment is found to be safer and more effective than other treatments
available to your doctor. In this case, clinical trial participants are the first to benefit from it.
However, there can be risks from new medical treatments, like side effects.
Sometimes, however, a medication or treatment is less effective or even harmful. If the new treatment proves to
be harmful or less effective before the trial is completed, your doctor will often decide to take you out of the
clinical trial and do whatever is best for you. It is important that you know the benefits and risks of a new
treatment before volunteering to participate in a clinical trial.
Informed consent is used for this purpose. This form describes the
clinical trial and lists the benefits and risks of each treatment. Before any treatment is given, you must be
told about these benefits and risks. You cannot be entered into a clinical trial until you sign the informed
What Protections Exist for People Who Participate in Clinical Trials?
Your rights as a volunteer in a clinical trial are protected in three ways. You must be
adequately informed about the clinical trial. The clinical trial must be approved and
continually monitored by an independent Institutional Review Board (IRB) or a
Human Rights Committee (HRC) at your medical facility. An independent
Monitoring Committee (DMC) established by the Cooperative Studies Program
monitors each clinical trial.
The informed consent document that you must read and sign before you participate in a
trial will explain the benefits and risks of the clinical trial.
Unique to the VA system is a Research and Development Committee at each VA
medical center performing medical research, including clinical trials. This committee
evaluates the scientific value of each research study performed at that VA. The
committee's purpose is to make sure the research project will answer an important
medical question. These committees provide another layer of protection for subjects
participating in VA research projects.
Remember, you have the right to make your own decisions about your medical care.
The decision to participate in a clinical trial is entirely yours. Talk with your doctor about
all the medical treatments, including those being used in the clinical trial, that are
available to you. This will help you make the best choices for your health.
|Institutional Review Board or
Human Rights Committee
|Data Monitoring Committee
- At least five members who have the qualifications and experience to review and evaluate the science,
medical aspects, and ethics of the trial.
- Six to eight members: experts in the subject
matter and other appropriate technical or scientific specialists.
- Initially approves the trial.
- Protect the rights and welfare of the participants in the clinical trial.
- Make sure the trial should continue.
- Assure that participants are not harmed by the trial.
- Before and every year after the trial starts.
- Every 6-12 months after the trial starts.
|Evaluates studies for:
- Risk to participants.
- Ensuring benefits outweigh risks.
- Whether treatment group selection is random.
- Determining Informed consent is given by each patient in writing.
- Data monitoring to assure safety.
- Ensuring patient records are kept confidential.
- Benefits to clinical trial participants.
- Harm to clinical trial participants.
- Whether the questions raised by the trial are still medically / scientifically important.
|Will stop a trial if:
(DMC only has authority to recommend stopping the clinical trial.)
- Welfare of participants is at risk.
- Informed consent procedures are not followed or consent is not given.
- Annual review does not occur.
- Treatment is obviously harmful to participants.
- The treatment is obviously much better than the standard treatment or placebo.
- Recommended changes in the trial are not made.
- Welfare of participants is at risk.
- Treatment is obviously harmful to participants.
- Question is no longer relevant or has been answered by another clinical trial.
What Is Informed Consent?
Informed consent is required for all clinical trials. It means that you have been told and understand
exactly what will be done in the clinical trial. If you are interested in being participant, you will
be given an informed consent form to read and think about carefully. This form must include the
- A statement that the clinical trial involves research.
- A statement about who is doing the research.
- An explanation of the purpose of the clinical trial.
- An indication as to how long you will be expected to participate in the clinical trial.
- A description of the procedures that you will be required to follow during the clinical trial.
- The identification of any procedures that are experimental or not a part of your routine medical care.
- A description of any possible risks or discomforts because of your participation in the clinical trial.
- A description of any benefits to you because of your participation in the clinical trial.
- A description of alternative procedures available outside the clinical trial.
- A statement that your medical records will be kept confidential except for review by VA researchers, VA officials, the local IRB and perhaps the Food and Drug Administration.
- An explanation as to what compensation or medical treatments will be available if you are injured during your participation in the clinical trial.
- Whom to contact for answers about the clinical trial and your rights.
- Whom to contact if an injury occurs.
- A statement that your participation in the clinical trial is strictly voluntary.
- A statement that your refusal to participate in the clinical trial will not result in any penalty or loss of benefits to you.
- A statement that you may stop participating in the clinical trial at any time without penalty or loss of benefits and the procedures for withdrawing.
- A statement that any new information about your medical treatment that becomes known during the clinical trial will be made available to you.
- The number of people participating in the clinical trial.
- Circumstances under which your participation in the clinical trial may be stopped by the doctor.
- Any additional cost to you because of participating in the clinical trial.
You have the freedom to decide whether you want to participate in a clinical trial.
At this point, it is important to ask as many questions as you may have. After the
doctor or nurse has answered all your questions completely, you can then decide
whether or not to participate. You may take the informed consent form home and
discuss it with family and friends before agreeing to participate. No one should
pressure you to participate in any clinical trial. If you decide to participate, you must
sign the informed consent form. If you decide not to participate, the doctor must treat
you or refer you to your regular doctor for standard medical treatment. You do not
have to explain why you choose not to participate. There are no penalties for not
participating in a clinical trial. You do not have to participate in a clinical trial just
because you signed an informed consent form. You may voluntarily withdraw from
the clinical trial at any time.
What Should You Know Before Participating in a Clinical Trial?
Having an illness can be physically and psychologically stressful. Deciding whether
to participate in a clinical trial is often an additional stress. The best way to feel
comfortable about your decision to participate is to get as much information as you can.
Be sure you understand the protocol and any tests you must take or samples you must
give. Make sure you also understand the following:
- The goal of the clinical trial. The following questions can help you find out why the clinical trial is being conducted:
- What question(s) is the trial trying to answer?
- What research has been done on this disease in the past?
- What other treatments are currently available for this disease?
- The clinical trial protocol. A clinical trial protocol is the treatment plan. Questions that you may want to ask about the protocol are:
- What medications, medical devices and/or procedures will be used during the trial?
- How long will I be asked to participate in the trial?
- Who can participate in the clinical trial?
- How much of my time is involved?
- Will there be any discomfort? If so, how severe will it be and how long will it last?
- Are there any costs to me?
- What happens if I am harmed by participating in the trial?
- How will my safety be monitored?
- Will I need follow-up care after the clinical trial ends? If so, for how long?
- Will I need to give blood or other bodily fluids?
- Will genetic testing be involved?
- What happens if I decide to drop out of the clinical trial?
- Benefits and risks. It is important to know how the treatment could affect your health. You should ask the following questions:
- How could my health improve from this clinical trial?
- What side effects can occur with the treatment?
- How will the clinical trial affect my daily life?
You may have other questions too. Write them down so you can ask the doctor or nurse
when you see them. You may involve others in your decision to participate in a clinical
trial. The opinions of family members, friends and your regular doctor may be valuable
to you. You may want to talk with others who are in the clinical trial. Ask if you can
meet with other participants who are in the clinical trial. Remember, the final decision is
Do not rush your decision. Make sure you feel comfortable about participating in the clinical
trial. Remember, if for any reason you wish to leave a trial, you may do so at any time.
Who Sponsors Clinical Trials?
The sponsor of a clinical trial can be a person, a government agency (like the
Department of Veterans Affairs or the National Institutes of Health), a university or a
pharmaceutical company who wants to answer a specific research question. The sponsor
is also responsible for the overall conduct of the clinical trial. The sponsor selects
qualified doctors to perform the research and it may pay for the research. The sponsor
also supplies detailed information to the doctors about the treatment being studied. Most
importantly, the sponsor monitors the progress of the clinical trial and makes sure the
protocol is followed.
Who Can Participate in a Clinical Trial?
Both healthy people and people with illnesses participate in clinical trials. Healthy people are
involved in Phase I studies, which determine the safety of a medication. For example, clinical
trials of vaccines (like the polio vaccine) often include healthy people. These people are usually
at risk for getting the disease the vaccine is meant to prevent. Most clinical trials, however,
involve people with a specific illness who may be helped by the new treatment. These kinds of
clinical trials are usually Phase II, Phase III and Phase IV trials.
There are often restrictions that specify who can be included in a clinical trial. The clinical
trial protocol will specify which participants can be included. The clinical trial doctor will
determine if you are eligible to participate in the trial.
What Is It Like to Participate in a Clinical Trial?
While participating in a clinical trial, you may receive more medical care than you would
normally receive. Many clinical trials may require that you have more tests and/or doctor
visits than usual. People participating in clinical trials are often seen by the clinical
trial doctors and nurses in the same places they receive their regular medical care. You
should not have to pay for any treatments or tests that you receive for participating in
a clinical trial.
You may also have to keep records or fill out forms about your health. The tests, visits
and time involved are described in the informed consent form. The visits may include an exam
of your health at the beginning of the clinical trial and several visits during the trial,
often referred to as patient follow-up. The clinical trial doctor or nurse may also keep in
touch with you for a while after the treatment in the trial is over.
Why is Patient Adherence to the Clinical Trial Treatment Plan Important?
Patient adherence is how well a patient follows the study
doctor and nurse's instructions. If you do not follow these instructions, the results of
the clinical trial may not be valid. For example, if you do not take the
clinical trial medication being studied
as directed, the medication may appear not to work when it really does work. The result
may be to deny you and other participants the treatment that is needed. Therefore,
patient adherence to the clinical trial instructions and procedures is extremely important
to all of us. If you are unable to perform any of the protocol procedures or take the clinical
trial medication, you should inform the clinical trial doctor or nurse, especially
if you experience any side effects from the treatment.
Clinical trials are very important in improving health and the care provided to patients.
We have given you some basic information about clinical trials. You may have other questions
about clinical trials that the CSP is planning or conducting. If you do, please ask your
doctor or nurse or visit studies section of this site.
Adherence - How well participants follow the treatment plan in a clinical trial.
Clinical trial - A study of medical treatments (medicines, devices or procedures).
Clinical trial medication - The medication being tested in a clinical trial.
Control group - The group of clinical trial participants who do not receive the new
treatment. These participants receive either a placebo or standard therapy.
Controlled clinical trial - A clinical trial that involves dividing participants into two
groups, treatment and control. In this type of clinical trial, participants are randomly
assigned to one of the two treatments.
Data Monitoring Committee (DMC) - A committee that reviews data from a
clinical trial to see if there is clear harm or benefit for participants while a clinical trial
is still on-going. This committee has the ability to stop a clinical trial early if necessary.
Double masked clinical trial - A clinical trial in which neither the participant nor the
clinical trial doctor/nurse know whether the participant is receiving the new treatment
or a standard treatment (or placebo).
Experimental group - The group of clinical trial participants that receive the new
Food and Drug Administration (FDA) - The government agency responsible for making
sure that drugs and medical devices are safe and effective.
Informed consent - A participant's right to know all the clinical trial's instructions and
procedures, all the risks and benefits of being in the clinical trial and have all his/her
questions answered before choosing whether to participate in the clinical trial. This
information must be given to the participant both verbally and in writing. Before a
participant can participate in a clinical trial, the participant must sign the clinical trial's
informed consent form. By signing the informed consent form, the participant
acknowledges that he/she understands what participation in the clinical trial will
involve and has made a decision to participate. See the section "What is Informed
Consent?" for a further explanation.
Institutional Review Board (IRB) or Human Rights Committee (HRC) - A committee that is
not a part of the clinical trial. This committee reviews and approves protocols to make
sure that participants are not exposed to unnecessary or excessive risks.
Medical device - A product that is made or constructed for a particular medical need or
purpose (hearing aid, dental implants, intraocular lens, etc.).
Phase I clinical trial - A clinical trial that tries to show the initial safety of a new
medication. These clinical trials are usually done in healthy volunteers.
Phase II clinical trial - A clinical trial that tries to see if the medication can work in
participants with the disease to be treated.
Phase III clinical trial - Phase IV clinical trial/Post-marketing surveillance participants
with the disease to be treated.
Phase IV clinical trial/Post-marketing surveillance - A clinical trial that is carried out
after a medicationis marketed or approved for licensing by the FDA. It evaluates the
medication's long-term effects.
Placebo - A tablet or capsule that contains no medication.
Protocol - A document that tells the clinical trial doctors how the clinical trial will be
Randomization - The process by which a clinical trial patient is assigned to a treatment
group by chance (like by the flip of a coin). Participants are randomly assigned to
receive either the new treatment or a standard treatment (or placebo).
Research and Development Committee - A committee formed at each VA facility doing
medical research. This committee is responsible for the review of the design of all
research projects involving humans. This committee also works closely with the
Institutional Review Board at the VA facility to make sure all legal and ethical issues are
Side effect - Any effect caused by a medication other than what was intended when a
patient takes a medicine.
Single masked clinical trial design - A clinical trial in which the participant does not
know whether he/she received the new treatment or a standard treatment (or placebo)
until the end of the clinical trial. In this type of clinical trial, the doctor and nurse are
aware of which treatment the patient is receiving.
Sponsor - The person, agency, university or pharmaceutical company who pays for the
Standard therapy/Standard treatment - The usual treatment for an illness to which a
new treatment may be compared. This is also known as the control.
Treatment group - The group of clinical trial participants that receive the new
Treatment plan - The way the medication will be used in a clinical trial. The plan is
described in the clinical trial's protocol.
Uncontrolled clinical trial - A clinical trial in which clinical trial doctor and nurse and
the participant know what medications are being used. This is also called an open-label
clinical trial .